Insider · CIK 0002054923
Udayan Guha
Files at NXTC (NextCure, Inc.). First filing -, latest -.
In brief
Udayan Guha files SEC Form 4 as officer at NXTC (NextCure, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Udayan Guha has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | NXTC NextCure, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +14,670 | $0.00 | $0 | 14,670 | Feb 3, 2026 |
Questions about Udayan Guha
Answered from the filings on this page, as of the latest one.
Is Udayan Guha buying or selling?
Udayan Guha has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Udayan Guha's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Udayan Guha has 0.
Where does Udayan Guha file Form 4?
Udayan Guha has filed Form 4 at NXTC (NextCure, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.